Wacker Chemie has opened its Wacker Biotechnology Center in Munich, in which the company has invested a double-digit million-euro sum in the facility.
“The Wacker Biotech Center will allow us to concentrate and intensify our biotech research activities. We see tremendous growth potential in this area, which is why we have decided to go ahead and invest in this sector, even in economically challenging times,” said Christian Hartel, Wacker CEO.
The Wacker Biotechnology Center is integrated into the group’s research site in the Munich quarter of Sendling, where the company has been conducting fundamental research for over a century and, since the 1980s, also in biotechnology. With the expansion of the biotechnology business, Wacker believed that its research capacities had reached their limits.
Focus on bioprocess production
Spread over four floors, the new building dedicates around 1,500 square meters for a laboratory and technical competence center and has 700 square meters of office space. It is home to the company’s research operations, including methods to manufacture biopharmaceuticals. The focus will be on processes for the production of proteins and nucleic acids, which play an important role in developing innovative therapies involving, for example, active ingredients based on messenger ribonucleic acid (mRNA).
In addition, Wacker is committed to developing innovative ingredients for food and dietary supplements that contribute to healthy and sustainable nutrition for the generations of today and the future.
![Wacker Biotechnology Center moved into new building on the Group’s research location in Munich. Photovoltaic panels adorn the facade of the Biotechnology Center. [WACKER]](https://www.genengnews.com/wp-content/uploads/2025/07/wacker_biotechnology_center_wr_img_635-300x200.jpg)
Consolidating biotechnological R&D under one roof will go a long way in improving the efficiency of Wacker’s research activities, predicts Hartel. Apart from optimizing efficiency, Wacker is also keen on reducing the time from lab-based research and product development to actual implementation.
“It is no longer enough to simply have the best solution. It’s becoming increasingly important that we reach the customer with this solution first. Speed is taking on an ever greater role in making us stand out,” emphasizes Hartel.
